Neovacs appoints Piers Whitehead as VP of Corporate Development
Advertisement
Neovacs announced that Piers Whitehead has joined the Company`s management team as VP Corporate Development. Mr Whitehead has over 15 years experience in the life sciences as both a senior executive and a consultant, and has led and negotiated transactions in Europe, the US, Japan and Korea.
Prior to joining Neovacs, Mr. Whitehead was a consultant providing counsel to biotechnology companies on business and corporate development. Previously, he was Vice President of Business and Corporate Development for VaxGen Inc., a public US biotechnology company, and prior to that he was a Vice President of Mercer Management Consulting (now Oliver Wyman), where he headed that firm’s San Francisco office. He graduated from Oriel College, Oxford.